FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367678909> ?p ?o ?g. }

• W4367678909 abstract "Background Acute Myeloid leukemia is a heterogeneous disease that requires novel targeted treatment options tailored to the patients’ specific microenvironment and blast phenotype. Methods We characterized bone marrow and/or blood samples of 37 AML patients and healthy donors by high dimensional flow cytometry and RNA sequencing using computational analysis. In addition, we performed ex vivo ADCC assays using allogeneic NK cells isolated from healthy donors and AML patient material to test the cytotoxic potential of CD25 Mab (also referred to as RG6292 and RO7296682) or isotype control antibody on regulatory T cells and CD25+ AML cells. Results Bone marrow composition, in particular the abundance of regulatory T cells and CD25 expressing AML cells, correlated strongly with that of the blood in patients with time-matched samples. In addition, we observed a strong enrichment in the prevalence of CD25 expressing AML cells in patients bearing a FLT3-ITD mutation or treated with a hypomethylating agent in combination with venetoclax. We adopted a patient-centric approach to study AML clusters with CD25 expression and found it most highly expressed on immature phenotypes. Ex vivo treatment of primary AML patient samples with CD25 Mab, a human CD25 specific glycoengineered IgG1 antibody led to the specific killing of two different cell types, CD25+ AML cells and regulatory T cells, by allogeneic Natural Killer cells. Conclusion The in-depth characterization of patient samples by proteomic and genomic analyses supported the identification of a patient population that may benefit most by harnessing CD25 Mab’s dual mode of action. In this pre-selected patient population, CD25 Mab could lead to the specific depletion of regulatory T cells, in addition to leukemic stem cells and progenitor-like AML cells that are responsible for disease progression or relapse." @default.
• W4367678909 created "2023-05-03" @default.
• W4367678909 creator A5000838010 @default.
• W4367678909 creator A5003430521 @default.
• W4367678909 creator A5005575723 @default.
• W4367678909 creator A5011813192 @default.
• W4367678909 creator A5012253135 @default.
• W4367678909 creator A5047711932 @default.
• W4367678909 creator A5048621211 @default.
• W4367678909 creator A5054904210 @default.
• W4367678909 creator A5061516661 @default.
• W4367678909 creator A5067162282 @default.
• W4367678909 creator A5070540897 @default.
• W4367678909 date "2023-05-02" @default.
• W4367678909 modified "2023-09-30" @default.
• W4367678909 title "CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia" @default.
• W4367678909 cites W1631320694 @default.
• W4367678909 cites W1915923979 @default.
• W4367678909 cites W1988224733 @default.
• W4367678909 cites W1991286650 @default.
• W4367678909 cites W2005691176 @default.
• W4367678909 cites W2046883752 @default.
• W4367678909 cites W2047122678 @default.
• W4367678909 cites W2064453188 @default.
• W4367678909 cites W2098394317 @default.
• W4367678909 cites W2116967305 @default.
• W4367678909 cites W2138207763 @default.
• W4367678909 cites W2139276258 @default.
• W4367678909 cites W2163123363 @default.
• W4367678909 cites W2169456326 @default.
• W4367678909 cites W2169649037 @default.
• W4367678909 cites W2174167009 @default.
• W4367678909 cites W2300046162 @default.
• W4367678909 cites W2342267791 @default.
• W4367678909 cites W2513682949 @default.
• W4367678909 cites W2585283489 @default.
• W4367678909 cites W2607137647 @default.
• W4367678909 cites W2618202329 @default.
• W4367678909 cites W2811405063 @default.
• W4367678909 cites W2893372497 @default.
• W4367678909 cites W2898284215 @default.
• W4367678909 cites W2904615517 @default.
• W4367678909 cites W2904928050 @default.
• W4367678909 cites W2914396734 @default.
• W4367678909 cites W2916458303 @default.
• W4367678909 cites W2917646500 @default.
• W4367678909 cites W2921992800 @default.
• W4367678909 cites W2980226546 @default.
• W4367678909 cites W2982254481 @default.
• W4367678909 cites W2991954871 @default.
• W4367678909 cites W2998012982 @default.
• W4367678909 cites W3005295900 @default.
• W4367678909 cites W3009044884 @default.
• W4367678909 cites W3025011805 @default.
• W4367678909 cites W3033706053 @default.
• W4367678909 cites W3046771604 @default.
• W4367678909 cites W3082485747 @default.
• W4367678909 cites W3083003645 @default.
• W4367678909 cites W3098454574 @default.
• W4367678909 cites W3130903278 @default.
• W4367678909 cites W3159397045 @default.
• W4367678909 cites W3179573133 @default.
• W4367678909 cites W3187124736 @default.
• W4367678909 cites W3196440955 @default.
• W4367678909 cites W3206235705 @default.
• W4367678909 cites W3213198617 @default.
• W4367678909 cites W3213442860 @default.
• W4367678909 cites W3215605010 @default.
• W4367678909 cites W4280489399 @default.
• W4367678909 cites W4282964417 @default.
• W4367678909 cites W4283458368 @default.
• W4367678909 doi "https://doi.org/10.3389/fonc.2023.1150149" @default.
• W4367678909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37205201" @default.
• W4367678909 hasPublicationYear "2023" @default.
• W4367678909 type Work @default.
• W4367678909 citedByCount "0" @default.
• W4367678909 crossrefType "journal-article" @default.
• W4367678909 hasAuthorship W4367678909A5000838010 @default.
• W4367678909 hasAuthorship W4367678909A5003430521 @default.
• W4367678909 hasAuthorship W4367678909A5005575723 @default.
• W4367678909 hasAuthorship W4367678909A5011813192 @default.
• W4367678909 hasAuthorship W4367678909A5012253135 @default.
• W4367678909 hasAuthorship W4367678909A5047711932 @default.
• W4367678909 hasAuthorship W4367678909A5048621211 @default.
• W4367678909 hasAuthorship W4367678909A5054904210 @default.
• W4367678909 hasAuthorship W4367678909A5061516661 @default.
• W4367678909 hasAuthorship W4367678909A5067162282 @default.
• W4367678909 hasAuthorship W4367678909A5070540897 @default.
• W4367678909 hasBestOaLocation W43676789091 @default.
• W4367678909 hasConcept C150903083 @default.
• W4367678909 hasConcept C159654299 @default.
• W4367678909 hasConcept C203014093 @default.
• W4367678909 hasConcept C207001950 @default.
• W4367678909 hasConcept C26291073 @default.
• W4367678909 hasConcept C2776090121 @default.
• W4367678909 hasConcept C2778729363 @default.
• W4367678909 hasConcept C2779282312 @default.
• W4367678909 hasConcept C2780007613 @default.
• W4367678909 hasConcept C40677261 @default.
• W4367678909 hasConcept C502942594 @default.

• next